DISCOUNT-ZERTIFIKAT - STRATEC BIOMEDICAL Stock

Certificat

DE000DW3PPF7

Market Closed - Börse Stuttgart 02:25:55 2024-06-07 am EDT
46.92 EUR -2.21% Intraday chart for DISCOUNT-ZERTIFIKAT - STRATEC BIOMEDICAL
Current month+0.79%
1 month+10.97%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-07 46.92 -2.21%
24-06-06 47.98 +0.17%
24-06-05 47.9 +0.13%
24-06-04 47.84 -0.06%
24-06-03 47.87 +2.84%

Delayed Quote Börse Stuttgart

Last update June 07, 2024 at 02:25 am EDT

More quotes

Static data

Product typeCertificats Discount
Buy / SellCALL
Underlying STRATEC SE
Issuer DZ BANK
WKN DW3PPF
ISINDE000DW3PPF7
Date issued 2022-06-27
Cap 56
Last trading day 2024-06-21
Maturity 2024-06-21 (13 Days)
Parity 1 : 1
Emission price 49.24
Emission volume N/A
Payment day 2024-06-28
Bonus-
Settlement règlement en espèces
Currency EUR

Technical Indicators

Discount (ask) 0.000000 %
Sideways yield 0.000000 %
Sideways yield pa 0.000000 %
Outperformance point-
Break even 0.000000 €
Highest since issue 51.09
Lowest since issue 35.75
Distance Cap -8.65
Distance Cap %-18.27%
Max. earning-
Max. earning % 0.000000 %

Company Profile

Stratec SE is a Germany-based company engaged in the development and manufacture of fully automated systems based on its own patented technologies for its partners in the fields of in-vitro diagnostics and life sciences in Germany and internationally. Its business activities are divided into three segments: Instrumentation, which designs and manufactures fully automated analyzer systems for its clinical diagnostics and biotechnology customers; Diatron, which offers systems, system components, consumables, and tests for the low throughput hematology and clinical chemistry applications, and Consumables, which develops and sells scientific materials, such as nucleic acid purification and designs and produces smart consumables in the fields of diagnostics, life sciences, and medical technology. In addition, the Company develops workflow software for networking various analyzer systems, as well as develops and sells scientific materials and technologies.
Sector
-
More about the company

Ratings for Stratec SE

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Stratec SE

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
47.35 EUR
Average target price
42.33 EUR
Spread / Average Target
-10.59%
Consensus